News
Platform and product releases span OPUS, MINT, POET, and SPI.
TraceLink's customer base has exchanged more than 15 million DSCSA transactions to date, and has grown to more than 850 companies, ranging across pharmaceutical manufacturers, contract ...
TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the life sciences and healthcare supply chain, today announced significant new platform enhancements to ...
Dahod’s company, TraceLink Inc., is preparing to capitalize on the Drug Supply Chain Security Act, passed in 2013 along with similar laws and regulations taking effect in coming years in Europe ...
TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, today announced the successful completion of its ISO 9001:2015 annual surveillance audit ...
TraceLink rode the wave of pharmaceutical serialization requirements to success, positioning its software as a data connector for Big Pharma, contract manufacturers and healthcare providers alike.
TraceLink, a nine-year-old, software-as-a-service platform for tracking pharmaceuticals and trying to weed out counterfeit prescription drugs in the process, has raised $93 million in Series D ...
TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the life sciences and healthcare supply chain, proudly announces it has become the first and only solution ...
By acquiring ROC IT and integrating the industry-leading edge solution, EdgeTRAC™, into its family of serialization software solutions, TraceLink now offers solutions for serialized receiving ...
Using TraceLink's platform applications like Multienterprise Information Network Tower (MINT), customers can deploy proven B2B integration and process orchestration capabilities enabled by Opus to ...
TraceLink, the SaaS platform for tracking and tracing pharmaceuticals, has today announced the close of a $51.5 million Series C financing led by Goldman Sachs Growth Equity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results